Current Alzheimer’s disease (AD) treatments show limited effectiveness and significant side effects, creating a need for new therapeutic options.
Recent research has identified three new proaporphine alkaloids from the medicinal plant L.f., namely cissamaline, cissamanine, and cissamdine, which may have neuroprotective properties.
Studies indicate these compounds have favorable pharmacokinetic profiles and potentially strong interactions with AD-related proteins, making them promising candidates for further research as novel treatments for Alzheimer’s disease.